Hypokalemia (Figure 9)
Three out of five studies [5,10,14] reported investigator-reported hypokalemia, and the pooled analysis revealed that treatment with Finerenone was associated with a significantly lower risk of hypokalemia compared to patients treated with placebo (RR = 0.47 [0.38, 0.57] p 0. 00001; I2= 0%).